{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:48:42Z","timestamp":1792604922295,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701298"],"award-info":[{"award-number":["81701298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00011-021-01532-4","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T19:03:06Z","timestamp":1642100586000},"page":"191-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy"],"prefix":"10.1007","volume":"71","author":[{"given":"Changjiang","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-0491","authenticated-orcid":false,"given":"Xiaoyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"1532_CR1","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2337\/dc20-1688","volume":"44","author":"V Ahuja","year":"2021","unstructured":"Ahuja V, et al. Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis. Diabetes Care. 2021;44:1062\u20139. https:\/\/doi.org\/10.2337\/dc20-1688.","journal-title":"Diabetes Care"},{"key":"1532_CR2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.248","author":"JKN Chan","year":"2021","unstructured":"Chan JKN, Wong CSM, Or PCF, Chen EYH, Chang WC. Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study. Br J Psychiatry. 2021. https:\/\/doi.org\/10.1192\/bjp.2020.248.","journal-title":"Br J Psychiatry"},{"key":"1532_CR3","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2337\/db20-0604","volume":"69","author":"A Advani","year":"2020","unstructured":"Advani A. Acute kidney injury: a bona fide complication of diabetes. Diabetes. 2020;69:2229\u201337. https:\/\/doi.org\/10.2337\/db20-0604.","journal-title":"Diabetes"},{"key":"1532_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101089","volume":"42","author":"T Dusabimana","year":"2020","unstructured":"Dusabimana T, et al. P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response. Mol Metab. 2020;42: 101089. https:\/\/doi.org\/10.1016\/j.molmet.2020.101089.","journal-title":"Mol Metab"},{"key":"1532_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/ars.2015.6372","volume":"24","author":"H Yuan","year":"2016","unstructured":"Yuan H, et al. Epigenetic histone modifications involved in profibrotic gene regulation by 12\/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal. 2016;24:361\u201375. https:\/\/doi.org\/10.1089\/ars.2015.6372.","journal-title":"Antioxid Redox Signal"},{"key":"1532_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.335","volume":"7","author":"WT Liu","year":"2016","unstructured":"Liu WT, et al. Metadherin facilitates podocyte apoptosis in diabetic nephropathy. Cell Death Dis. 2016;7: e2477. https:\/\/doi.org\/10.1038\/cddis.2016.335.","journal-title":"Cell Death Dis"},{"key":"1532_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmet.2019.02.007","volume":"23","author":"H Yang","year":"2019","unstructured":"Yang H, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-\u03baB\/TNF-\u03b1 pathway. Mol Metab. 2019;23:24\u201336. https:\/\/doi.org\/10.1016\/j.molmet.2019.02.007.","journal-title":"Mol Metab"},{"key":"1532_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.kint.2021.02.025","volume":"100","author":"L Wu","year":"2021","unstructured":"Wu L, et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 2021;100:107\u201321. https:\/\/doi.org\/10.1016\/j.kint.2021.02.025.","journal-title":"Kidney Int"},{"key":"1532_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41385-019-0181-1","volume":"12","author":"R Fang","year":"2019","unstructured":"Fang R, et al. ASC and NLRP3 maintain innate immune homeostasis in the airway through an inflammasome-independent mechanism. Mucosal Immunol. 2019;12:1092\u2013103. https:\/\/doi.org\/10.1038\/s41385-019-0181-1.","journal-title":"Mucosal Immunol"},{"key":"1532_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15532","author":"C Pellegrini","year":"2021","unstructured":"Pellegrini C, et al. NLRP3 at the crossroads between immune\/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity. Br J Pharmacol. 2021. https:\/\/doi.org\/10.1111\/bph.15532.","journal-title":"Br J Pharmacol"},{"key":"1532_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molmet.2018.02.001","volume":"10","author":"HL Kammoun","year":"2018","unstructured":"Kammoun HL, et al. Evidence against a role for NLRP3-driven islet inflammation in db\/db mice. Mol Metab. 2018;10:66\u201373. https:\/\/doi.org\/10.1016\/j.molmet.2018.02.001.","journal-title":"Mol Metab"},{"key":"1532_CR12","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2010020143","volume":"21","author":"A Vilaysane","year":"2010","unstructured":"Vilaysane A, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21:1732\u201344. https:\/\/doi.org\/10.1681\/ASN.2010020143.","journal-title":"J Am Soc Nephrol"},{"key":"1532_CR13","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00204-021-03157-2","volume":"95","author":"Z Li","year":"2021","unstructured":"Li Z, et al. Cadmium induces renal inflammation by activating the NLRP3 inflammasome through ROS\/MAPK\/NF-\u03baB pathway in vitro and in vivo. Arch Toxicol. 2021;95:3497\u2013513. https:\/\/doi.org\/10.1007\/s00204-021-03157-2.","journal-title":"Arch Toxicol"},{"key":"1532_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, et al. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling. Cell Death Dis. 2019;10:906. https:\/\/doi.org\/10.1038\/s41419-019-2157-1.","journal-title":"Cell Death Dis"},{"key":"1532_CR15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.1600760","volume":"198","author":"MS Cheung","year":"2017","unstructured":"Cheung MS, et al. Periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome is associated with a CARD8 variant unable to bind the NLRP3 inflammasome. J Immunol. 2017;198:2063\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1600760.","journal-title":"J Immunol"},{"key":"1532_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.41245","volume":"72","author":"G Yang","year":"2020","unstructured":"Yang G, et al. Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis. Arthritis Rheumatol. 2020;72:1192\u2013202. https:\/\/doi.org\/10.1002\/art.41245.","journal-title":"Arthritis Rheumatol"},{"key":"1532_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173503","volume":"885","author":"C Ram","year":"2020","unstructured":"Ram C, et al. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: preclinical evidences with therapeutic approaches. Eur J Pharmacol. 2020;885: 173503. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173503.","journal-title":"Eur J Pharmacol"},{"key":"1532_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154748","volume":"118","author":"M Wu","year":"2021","unstructured":"Wu M, et al. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism. 2021;118: 154748. https:\/\/doi.org\/10.1016\/j.metabol.2021.154748.","journal-title":"Metabolism"},{"key":"1532_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneph.2015.175","volume":"12","author":"J Wada","year":"2016","unstructured":"Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12:13\u201326. https:\/\/doi.org\/10.1038\/nrneph.2015.175.","journal-title":"Nat Rev Nephrol"},{"key":"1532_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0217-3","volume":"51","author":"D Kim","year":"2019","unstructured":"Kim D, Li HY, Lee JH, Oh YS, Jun HS. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1\/MAPK\/KLF5 signaling. Exp Mol Med. 2019;51:1\u201310. https:\/\/doi.org\/10.1038\/s12276-019-0217-3.","journal-title":"Exp Mol Med"},{"key":"1532_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1681\/asn.2013111213","volume":"26","author":"TH Yoo","year":"2015","unstructured":"Yoo TH, et al. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J Am Soc Nephrol. 2015;26:133\u201347. https:\/\/doi.org\/10.1681\/asn.2013111213.","journal-title":"J Am Soc Nephrol"},{"key":"1532_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150886","volume":"11","author":"M Nagase","year":"2016","unstructured":"Nagase M, Kurihara H, Aiba A, Young MJ, Sakai T. Deletion of Rac1GTPase in the myeloid lineage protects against inflammation-mediated kidney injury in mice. PLoS\u00a0One. 2016;11: e0150886. https:\/\/doi.org\/10.1371\/journal.pone.0150886.","journal-title":"PLoS\u00a0One"},{"key":"1532_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124433","author":"D Hirohama","year":"2020","unstructured":"Hirohama D, et al. PGI2 analog attenuates salt-induced renal injury through the inhibition of inflammation and Rac1-MR activation. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21124433.","journal-title":"Int J Mol Sci"},{"key":"1532_CR24","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.ajpath.2014.06.013","volume":"184","author":"L Lin","year":"2014","unstructured":"Lin L, Jin Y, Mars WM, Reeves WB, Hu K. Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-\u03baB pathways. Am J Pathol. 2014;184:2757\u201367. https:\/\/doi.org\/10.1016\/j.ajpath.2014.06.013.","journal-title":"Am J Pathol"},{"key":"1532_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41419-018-0353-z","volume":"9","author":"Z Lv","year":"2018","unstructured":"Lv Z, et al. Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice. Cell Death Dis. 2018;9:342. https:\/\/doi.org\/10.1038\/s41419-018-0353-z.","journal-title":"Cell Death Dis"},{"key":"1532_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.587663","volume":"11","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Bu-Shen-Huo-Xue decoction ameliorates diabetic nephropathy by inhibiting Rac1\/PAK1\/p38MAPK signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice. Front Pharmacol. 2020;11: 587663. https:\/\/doi.org\/10.3389\/fphar.2020.587663.","journal-title":"Front Pharmacol"},{"key":"1532_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184531","author":"W Garrido","year":"2019","unstructured":"Garrido W, et al. Blockade of the Adenosine A3 receptor attenuates caspase 1 activation in renal tubule epithelial cells and decreases interleukins IL-1\u03b2 and IL-18 in diabetic rats. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184531.","journal-title":"Int J Mol Sci"},{"key":"1532_CR28","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/art.38174","volume":"65","author":"J Zhao","year":"2013","unstructured":"Zhao J, et al. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3\/ASC\/caspase 1 pathway. Arthritis Rheum. 2013;65:3176\u201385. https:\/\/doi.org\/10.1002\/art.38174.","journal-title":"Arthritis Rheum"},{"key":"1532_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2018.08.002","volume":"478","author":"M Wu","year":"2018","unstructured":"Wu M, et al. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol. 2018;478:115\u201325. https:\/\/doi.org\/10.1016\/j.mce.2018.08.002.","journal-title":"Mol Cell Endocrinol"},{"key":"1532_CR30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.ymthe.2021.03.012","volume":"29","author":"H Ding","year":"2021","unstructured":"Ding H, et al. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. Mol Ther. 2021;29:2308\u201320. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.012.","journal-title":"Mol Ther"},{"key":"1532_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153314","volume":"78","author":"ZZ Tang","year":"2020","unstructured":"Tang ZZ, et al. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: in vivo and in vitro study. Phytomedicine. 2020;78: 153314. https:\/\/doi.org\/10.1016\/j.phymed.2020.153314.","journal-title":"Phytomedicine"},{"key":"1532_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119542","volume":"278","author":"L Zhang","year":"2021","unstructured":"Zhang L, Jing M, Liu Q. Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes. Life Sci. 2021;278: 119542. https:\/\/doi.org\/10.1016\/j.lfs.2021.119542.","journal-title":"Life Sci"},{"key":"1532_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ki.2014.271","volume":"87","author":"K Shahzad","year":"2015","unstructured":"Shahzad K, et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015;87:74\u201384. https:\/\/doi.org\/10.1038\/ki.2014.271.","journal-title":"Kidney Int"},{"key":"1532_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102033","volume":"45","author":"X Dai","year":"2021","unstructured":"Dai X, et al. Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol. 2021;45: 102033. https:\/\/doi.org\/10.1016\/j.redox.2021.102033.","journal-title":"Redox Biol"},{"key":"1532_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1681\/asn.2014111136","volume":"27","author":"R Mohamed","year":"2016","unstructured":"Mohamed R, et al. Low-Dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis. J Am Soc Nephrol. 2016;27:745\u201365. https:\/\/doi.org\/10.1681\/asn.2014111136.","journal-title":"J Am Soc Nephrol"},{"key":"1532_CR36","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1681\/asn.2015060676","volume":"27","author":"K Shahzad","year":"2016","unstructured":"Shahzad K, et al. Caspase-1, but not caspase-3, promotes diabetic nephropathy. J Am Soc Nephrol. 2016;27:2270\u20135. https:\/\/doi.org\/10.1681\/asn.2015060676.","journal-title":"J Am Soc Nephrol"},{"key":"1532_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/db15-0473","volume":"65","author":"A Tagawa","year":"2016","unstructured":"Tagawa A, et al. Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes. 2016;65:755\u201367. https:\/\/doi.org\/10.2337\/db15-0473.","journal-title":"Diabetes"},{"key":"1532_CR38","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.kint.2016.06.035","volume":"90","author":"M Garsen","year":"2016","unstructured":"Garsen M, et al. Cathepsin L is crucial for the development of early experimental diabetic nephropathy. Kidney Int. 2016;90:1012\u201322. https:\/\/doi.org\/10.1016\/j.kint.2016.06.035.","journal-title":"Kidney Int"},{"key":"1532_CR39","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.kint.2016.09.032","volume":"91","author":"J Wysocki","year":"2017","unstructured":"Wysocki J, et al. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy. Kidney Int. 2017;91:1336\u201346. https:\/\/doi.org\/10.1016\/j.kint.2016.09.032.","journal-title":"Kidney Int"},{"key":"1532_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/joim.12548","volume":"281","author":"NJ Brunskill","year":"2017","unstructured":"Brunskill NJ. C-peptide and diabetic kidney disease. J Intern Med. 2017;281:41\u201351. https:\/\/doi.org\/10.1111\/joim.12548.","journal-title":"J Intern Med"},{"key":"1532_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.ijbiomac.2019.04.069","volume":"133","author":"T Li","year":"2019","unstructured":"Li T, Hua Q, Li N, Cui Y, Zhao M. Protective effect of a polysaccharide from Dipsacus asper Wall on streptozotocin (STZ)-induced diabetic nephropathy in rat. Int J Bio Macromol. 2019;133:1194\u2013200. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.04.069.","journal-title":"Int J Bio Macromol"},{"key":"1532_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-019-1177-1","volume":"10","author":"J Jin","year":"2019","unstructured":"Jin J, et al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10:95. https:\/\/doi.org\/10.1186\/s13287-019-1177-1.","journal-title":"Stem Cell Res Ther"},{"key":"1532_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1681\/asn.2016020237","volume":"28","author":"C Recio","year":"2017","unstructured":"Recio C, et al. Suppressor of cytokine signaling-1 peptidomimetic limits progression of diabetic nephropathy. J Am Soc Nephrol. 2017;28:575\u201385. https:\/\/doi.org\/10.1681\/asn.2016020237.","journal-title":"J Am Soc Nephrol"},{"key":"1532_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ki.2014.322","volume":"87","author":"N Sakai","year":"2015","unstructured":"Sakai N, Wada T. Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells. Kidney Int. 2015;87:12\u20134. https:\/\/doi.org\/10.1038\/ki.2014.322.","journal-title":"Kidney Int"},{"key":"1532_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.kint.2017.05.013","volume":"93","author":"G Liang","year":"2018","unstructured":"Liang G, et al. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney Int. 2018;93:95\u2013109. https:\/\/doi.org\/10.1016\/j.kint.2017.05.013.","journal-title":"Kidney Int"},{"key":"1532_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jnutbio.2018.06.002","volume":"60","author":"E Sierra-Mondragon","year":"2018","unstructured":"Sierra-Mondragon E, et al. All-trans retinoic acid ameliorates inflammatory response mediated by TLR4\/NF-\u03baB during initiation of diabetic nephropathy. J Nutr Biochem. 2018;60:47\u201360. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.06.002.","journal-title":"J Nutr Biochem"},{"key":"1532_CR47","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/ki.2014.116","volume":"86","author":"D Verzola","year":"2014","unstructured":"Verzola D, et al. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int. 2014;86:1229\u201343. https:\/\/doi.org\/10.1038\/ki.2014.116.","journal-title":"Kidney Int"},{"key":"1532_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3389\/fimmu.2020.01270","volume":"11","author":"T Salti","year":"2020","unstructured":"Salti T, et al. Glucose induces IL-1\u03b1-dependent inflammation and extracellular matrix proteins expression and deposition in renal tubular epithelial cells in diabetic kidney disease. Front Immunol. 2020;11:1270. https:\/\/doi.org\/10.3389\/fimmu.2020.01270.","journal-title":"Front Immunol"},{"key":"1532_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, et al. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis. 2021;12:523. https:\/\/doi.org\/10.1038\/s41419-021-03813-6.","journal-title":"Cell Death Dis"},{"key":"1532_CR50","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102201","volume":"39","author":"XD Yang","year":"2020","unstructured":"Yang XD, et al. PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome. EMBO J. 2020;39: e102201. https:\/\/doi.org\/10.15252\/embj.2019102201.","journal-title":"EMBO J"},{"key":"1532_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.630569","volume":"12","author":"A Alatshan","year":"2021","unstructured":"Alatshan A, Benk\u0151 S. Nuclear receptors as multiple regulators of NLRP3 inflammasome function. Front Immunol. 2021;12: 630569. https:\/\/doi.org\/10.3389\/fimmu.2021.630569.","journal-title":"Front Immunol"},{"key":"1532_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.373","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. NLRP3 inflammasome of renal tubular epithelial cells induces kidney injury in acute hemolytic transfusion reactions. Clin Transl Med. 2021;11: e373. https:\/\/doi.org\/10.1002\/ctm2.373.","journal-title":"Clin Transl Med"},{"key":"1532_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2019.01.014","volume":"96","author":"SR Mulay","year":"2019","unstructured":"Mulay SR. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases. Kidney Int. 2019;96:58\u201366. https:\/\/doi.org\/10.1016\/j.kint.2019.01.014.","journal-title":"Kidney Int"},{"key":"1532_CR54","doi-asserted-by":"publisher","first-page":"17254","DOI":"10.1073\/pnas.1415756111","volume":"111","author":"B Guey","year":"2014","unstructured":"Guey B, Bodnar M, Mani\u00e9 SN, Tardivel A, Petrilli V. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function. Proc Natl Acad Sci USA. 2014;111:17254\u20139. https:\/\/doi.org\/10.1073\/pnas.1415756111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1532_CR55","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1073\/pnas.1012455108","volume":"108","author":"AH Ellebedy","year":"2011","unstructured":"Ellebedy AH, et al. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci USA. 2011;108:2927\u201332. https:\/\/doi.org\/10.1073\/pnas.1012455108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1532_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2017.02.027","volume":"106","author":"SM Conley","year":"2017","unstructured":"Conley SM, et al. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia. Free Radic Biol Med. 2017;106:236\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.02.027.","journal-title":"Free Radic Biol Med"},{"key":"1532_CR57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000500457","volume":"44","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Conley SM, Li G, Yuan X, Li PL. Rac1 GTPase inhibition blocked podocyte injury and glomerular sclerosis during hyperhomocysteinemia via suppression of nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 inflammasome activation. Kidney Blood Press Res. 2019;44:513\u201332. https:\/\/doi.org\/10.1159\/000500457.","journal-title":"Kidney Blood Press Res"},{"key":"1532_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030379","volume":"7","author":"J Eitel","year":"2012","unstructured":"Eitel J, et al. Rac1 regulates the NLRP3 inflammasome which mediates IL-1beta production in Chlamydophila pneumoniae infected human mononuclear cells. PLoS\u00a0One. 2012;7: e30379. https:\/\/doi.org\/10.1371\/journal.pone.0030379.","journal-title":"PLoS\u00a0One"},{"key":"1532_CR59","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, et al. Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation. Nat Commun. 2020;11:1659. https:\/\/doi.org\/10.1038\/s41467-020-15497-1.","journal-title":"Nat Commun"},{"key":"1532_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.679166","volume":"12","author":"C Ying","year":"2021","unstructured":"Ying C, et al. Ras-related C3 botulinum toxin substrate 1 combining with the mixed lineage kinase 3- mitogen-activated protein kinase 7- c-Jun N-terminal kinase signaling module accelerates diabetic nephropathy. Front Physiol. 2021;12: 679166. https:\/\/doi.org\/10.3389\/fphys.2021.679166.","journal-title":"Front Physiol"},{"key":"1532_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119226","volume":"274","author":"N Fang","year":"2021","unstructured":"Fang N, Li P. O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1\/PTEN axis. Life Sci. 2021;274: 119226. https:\/\/doi.org\/10.1016\/j.lfs.2021.119226.","journal-title":"Life Sci"},{"key":"1532_CR62","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1369\/jhc.7A7266.2007","volume":"55","author":"N Terada","year":"2007","unstructured":"Terada N, et al. Interaction of membrane skeletal protein, protein 4.1B and p55, and sodium bicarbonate cotransporter1 in mouse renal S1\u2013S2 proximal tubules. J Histochem Cytochem. 2007;55:1199\u20132006. https:\/\/doi.org\/10.1369\/jhc.7A7266.2007.","journal-title":"J Histochem Cytochem"},{"key":"1532_CR63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.kint.2019.01.029","volume":"96","author":"T Lobry","year":"2019","unstructured":"Lobry T, et al. Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis. Kidney Int. 2019;96:350\u201362. https:\/\/doi.org\/10.1016\/j.kint.2019.01.029.","journal-title":"Kidney Int"},{"key":"1532_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005121","volume":"11","author":"H Yen","year":"2015","unstructured":"Yen H, et al. Enteropathogenic Escherichia coli uses NleA to inhibit NLRP3 inflammasome activation. PLoS Pathog. 2015;11: e1005121. https:\/\/doi.org\/10.1371\/journal.ppat.1005121.","journal-title":"PLoS Pathog"},{"key":"1532_CR65","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556\u20139. https:\/\/doi.org\/10.1038\/s41589-019-0277-7.","journal-title":"Nat Chem Biol"},{"key":"1532_CR66","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18:1141\u201360. https:\/\/doi.org\/10.1038\/s41423-021-00670-3.","journal-title":"Cell Mol Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01532-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-021-01532-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-021-01532-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T02:08:19Z","timestamp":1643422099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-021-01532-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s00011-021-01532-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All other authors confirm that no conflicts of interest relevant to this article exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}